National Path Lab
Liver & Gastrointestinal Diseases

Hepatitis C

Hepatitis C is a viral infection that can cause chronic liver inflammation, fibrosis, cirrhosis, and hepatocellular carcinoma. Laboratory testing generally begins with antibody testing and may require molecular confirmation.

A positive Anti-HCV result does not by itself establish active hepatitis C infection — HCV RNA testing is used to determine whether current infection is present.

At National Path Lab (NPL), comprehensive hepatitis C testing is available, including antibody screening and RNA-based confirmatory and monitoring tests.

Tests available
5
Tests available
Health package
1
Health package

Tests Available at NPL

LIVER FUNCTION TEST PANEL 1

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1000

COMPLETE BLOOD COUNT

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 500

HEPATITIS C ANTIBODY; ANTI HCV; QUANTITATIVE

Turn Around Time
SAMPLE DAILY BY 7:00 PM REPORT ON SAME DAY

Rs. 1800

HEPATITIS C VIRAL (HCV) RNA QUALITATIVE, REAL TIME PCR

Turn Around Time
SAMPLE BY MON/WED/FRI 8:00 AM, REPORT ON SAME DAY LATE EVENING

Rs. 8500

HEPATITIS C VIRAL (HCV) RNA QUANTITATIVE; HCV VIRAL LOAD, REAL TIME PCR

Turn Around Time
SAMPLE BY MON/WED/FRI 8:00 AM REPORT ON SAME DAY LATE EVENING

Rs. 9000

About Hepatitis C

Causes & Risk Factors

Hepatitis C is primarily transmitted through blood-to-blood contact:

•  Sharing needles or other injection equipment.

•  Receipt of blood products or medical procedures before adequate screening was in place.

•  Unsafe medical, dental, or cosmetic procedures involving inadequately sterilized equipment.

•  Mother-to-child transmission, though less common than with hepatitis B.

•  Sexual transmission, though generally less efficient than with hepatitis B or HIV.

Symptoms & When to Test

Hepatitis C is often called a "silent" infection because most people have no symptoms, especially in the early stages.

•  Often asymptomatic, particularly in early or chronic infection

•  Fatigue, when symptoms do occur

•  Unexplained elevated liver enzymes found incidentally

•  Symptoms of advanced liver disease in longstanding untreated infection

When Should You Consider Testing?

Testing is appropriate for risk factors such as past or current injection drug use, receipt of blood products before adequate screening, unexplained elevated liver enzymes, or known exposure to hepatitis C.

Why Tests Are Combined

Anti-HCV screens for past or current exposure, but a positive result alone cannot distinguish active infection from a cleared past infection — HCV RNA is needed to confirm whether the virus is currently present.

HCV RNA quantitative serves an additional purpose beyond diagnosis — it is used to monitor response to antiviral treatment, with successful treatment typically resulting in undetectable HCV RNA.

ALT/AST, bilirubin, albumin, and CBC/platelet count together assess the degree of liver injury and synthetic function, which is relevant both to disease staging and to monitoring for progression to more advanced liver disease.

Tests Available at NPL

Test Code

Test

Clinical Relevance

I0111

Anti-HCV

Screens for antibodies against hepatitis C virus.

N0012

HCV RNA

Detects hepatitis C viral RNA and helps establish current infection.

N0004

HCV RNA Quantitative

Measures viral RNA level; used for treatment assessment and monitoring.

B0046

LIVER FUNCTION TEST PANEL 1

Evaluates liver injury.

H0012

 

CBC

Helps assess overall status and may provide information relevant to advanced liver disease.

Preparation requirements vary by specific test — please follow the instructions provided by your doctor or NPL for the tests ordered.

Home Sample Collection

NPL offers convenient home sample collection for Hepatitis C blood tests, so you don't need to visit a lab in person.

→ Book your test online, via the NPL app, or by calling +977 1 5970147 and select a convenient time slot for home sample collection.

→ A certified and experienced NPL phlebotomist visits your home at the scheduled time, following strict hygiene and safety protocols.

→ Your sample is transported under controlled, monitored conditions to NPL's NABL ACCREDITED UNDER ISO 15189:2022 laboratory for processing.

→ Your digital report is delivered securely to your phone or email, along with access to download and share it as needed.

When to See a Doctor

•  Known risk factors — past or current injection drug use, receipt of blood products before screening era

•  Unexplained elevated liver enzymes

•  Known exposure to hepatitis C

•  Positive Anti-HCV result requiring confirmatory RNA testing

•  Known hepatitis C infection — discuss antiviral treatment options

Medical Disclaimer

Laboratory tests support hepatitis C diagnosis and treatment monitoring but should not be interpreted in isolation. Reference ranges and clinical significance may vary according to the laboratory, patient characteristics, and clinical context. Final interpretation should be made by a qualified healthcare professional.

Related Packages

CELIAC PANEL SCREENING

Test Includes
3 Tests

Rs. 5000

Frequently Asked Questions

Not necessarily. Anti-HCV indicates exposure to HCV. HCV RNA testing is used to determine whether current infection is present, since some people clear the infection naturally.
Yes, in most cases. Modern direct-acting antiviral treatments can cure the majority of hepatitis C infections.
No, hepatitis C blood tests do not require fasting.
Successful treatment is generally confirmed by an undetectable HCV RNA result at a specified time after completing treatment.
Yes. Curing hepatitis C does not provide immunity against future infection, so ongoing risk-reduction measures remain important if risk factors persist.